ASCO 2020：11项中华人民共和国研究入选口头报告，17项Poster报告

曾受全球上新冠疫情严重影响，原定于5翌年29日~6翌年2日在芝加哥举行的美国外科协会（ASCO）年会今年将首次以里央线上形式举办，这是目前最大规模的里央线上盛会。时至今日，内阁会议的概述考题公布，共103个sessions，里国共有11项深入研究入选口头报告，17项入选Poster

Pyrotinib or lapatinib plus capecitabine for HER2+ metastatic breast cancer (PHOEBE): A randomized phase III trial.Session: Breast Cancer—MetastaticAuthor(s): Binghe Xu, Min Yan, Fei Ma, Xi-Chun Hu, Ji Feng Feng, Quchang Ouyang, Zhongsheng Tong, Huiping Li, Qingyuan Zhang, Tao Sun, Xian Wang, Yongmei Yin, Ying Cheng, Wei Li, Xiaoyu Zhu, Chunxia Chen, Jianjun ZouAbstract: 1003

萘替尼或卡马替尼加卡培他鹿岛用做HER2+集中于病态乳腺肺癌（PHOEBE）：一项III期随机次测试。

演奏会：集中于病态乳腺肺癌

写作者：里国医学科学院疗养院徐兵河任教、马飞任教，复旦大学原为疗养院胡夕春任教等

概述号：1003

Phase III trial of metronomic capecitabine maintenance after standard treatment in operable triple-negative breast cancer (SYSUCC-001).

Session: Breast Cancer—Local/Regional/Adjuvant

Author(s): XI Wang, Shu-Sen Wang, Heng Huang, Li Cai, Rou-Jun Peng, Li Zhao, Ying Lin, Jian Zeng, Le-Hong Zhang, Yong-Li Ke, Xian-Ming Wang, Xin-Mei Liu, Qian-Jun Chen, An-Qin Zhang, Dan-Mei Pang, Fei Xu, Jia J. Huang, Yanxia Shi, Jun Tang, Zhongyu Yuan

Abstract: 507

可手术后三阴病态乳腺肺癌标准复发后卡培他鹿岛维持节拍复发的III期次测试（SYSUCC-001）。

演奏会：乳腺肺癌—大面积/周边/除此以外复发

写作者：清华大学防治为里心王树森任教等

概述号：507

Utilizing phenotypic characteristics of metastatic brain tumors to predict the probability of circulating tumor DNA detection from cerebrospinal fluid.Session: New Tools to Combat Old FoesAuthor(s): Meichen Li, Delan Li, Xue Hou, Xiangheng Zhang, Na Wang, Jianzhong Liang, Jing Chen, Kaicheng Wang, Fufeng Wang, Yedan Chen, Xian Zhang, Hua Bao, Xue Wu, Xiaonan Wang, Yang Shao, Likun ChenAbstract: 2507

透过集中于病态脑的基因型形态来预测脑脊液里尿素DNA检测的机率: 上新物件对抗来由对手

演奏会：上新物件解决来由问题

写作者：蔡美芹 蔡德兰等

概述号: 2507

Donafenib versus sorafenib as first-line therapy in advanced hepatocellular carcinoma: An open-label, randomized, multicenter phase II/III trial.

Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Author(s): Feng Bi, Shukui Qin, Shanzhi Gu, Yuxian Bai, Zhendong Chen, Zishu Wang, Jieer Ying, Yinying Lu, Zhiqiang Meng, Hongming Pan, Ping Yang, Helong Zhang, Xi Chen, Aibing Xu, Xiufeng Liu, Qiu Meng, Liqing Wu, Feng Chen

Abstract: 4506

了了非尼对比索拉非尼作为里叶肠人体内肺癌的梯队复发：一项闭馆首页、随机、多为里心II/III期次测试。

演奏会：肠胃肠道肺癌—肠胃食管、肺癌变和实为

写作者：湖南大学毛脉疗养院毕锋任教、里国暴政解放军南开疗养院秦叔逵任教等

概述号：4506

Apatinib as second-line therapy in Chinese patients with advanced hepatocellular carcinoma: A randomized, placebo-controlled, double-blind, phase III study.

Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Author(s): Qiu Li, Shukui Qin, Shanzhi Gu, Xiaoming Chen, Lizhu Lin, Zishu Wang, Aibing Xu, Xi Chen, Cuncai Zhou, Zhenggang Ren, Lin Yang, Li Xu, Yuxian Bai, Lei Chen, Jun Li, Hongming Pan, Bangwei Cao, Weijia Fang, Ping Yan, Chunlei Jin

Abstract: 4507

里国里叶肠肺癌病变阿帕替尼二里央线复发：一项随机、安慰剂相符合、实证III期深入研究

演奏会：肠胃肠道肺癌—肠胃食管、肺癌变和实为

写作者：里国暴政解放军南开疗养院秦叔逵任教、湖南大学毛脉疗养院蔡秋任教等

概述号：4507

A randomized phase III trial of secondary cytoreductive surgery in later recurrent ovarian cancer: SOC1/SGOG-OV2.

Session: Gynecologic Cancer

Author(s): Rongyu Zang, Jianqing Zhu, Tingyan Shi, Jihong Liu, Dongsheng Tu, Sheng Yin, Rong Jiang, Ping Zhang, Huixun Jia, Yuting Luan, Yuqin Zhang, Xiaojun Chen, Xiao Huang, Wenjuan Tian, Wen Gao, Yanling Feng, Huijuan Yang, Xi Cheng, Yulang Cai

Abstract: 6001

里叶住院病态卵巢肺癌二次人体内减灭术的一项随机III期次测试：SOC1 / SGOG-OV2。

简介：妇科肺前列腺癌

写作者：复旦大学原为里山疗养院臧荣余任教等

概述：6001

Sequential chemoradiation versus radiation alone or concurrent chemoradiation in adjuvant treatment after radical hysterectomy for stage IB1-IIA2 cervical cancer (STARS Study): A randomized, controlled, open-label, phase III trial.

Session: Gynecologic Cancer

Author(s): He Huang, Yanling Feng, Ting Wan, Yanna Zhang, Xinping Cao, Yongwen Huang, Ying Xiong, Xin Huang, Min Zheng, Yanfang Li, Jundong Li, Guandi Chen, Hu Li, Yile Chen, Liguo Ma, Hongying Yang, Li Li, Shuzhong Yao, Qing Liu, Jihong Liu

Abstract: 6007

IB1-IIA2期宫颈肺癌根治病态子宫切除术后除此以外复发里的序贯放复发对比除此以外超声或连动放复发（STARS深入研究）：一项随机、相符合、闭馆首页的III期次测试。

内阁会议：妇科肺前列腺癌

写作者：清华大学防治为里心黄鹤任教、刘继红任教等

概述号：6007

CTONG1104: Adjuvant gefitinib versus chemotherapy for resected N1-N2 NSCLC with EGFR mutation—Final overall survival ysis of the randomized phase III trial 1 ysis of the randomized phase III trial.

Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Author(s): Yi-Long Wu, Wenzhao Zhong, Qun Wang, Weimin Mao, Song-Tao Xu, Lin Wu, Chun Chen, Ying Cheng, Lin Xu, Jun Wang, Xiao-Fei Li, Jian Li, Cheng Huang, Zhidong Liu, Shun Xu, Jin-Ji Yang, Hong-Hong Yan, Xue-Ning Yang, Si-yang Liu, Qing Zhou

Abstract: 9005

CTONG1104：除此以外吉非替尼对比复发用做可切除的EGFR基因型的N1-N2期NSCLC-随机III期外科次测试的最终总体生存数据分析。

简介：肠肺癌—非小人体内大面积-周边/小人体内/其他胸部

写作者：广东省暴政疗养院吴一龙任教等

概述号：9005

First-line tyrosine kinase inhibitor with or without aggressive upfront local radiation therapy in patients with EGFRm oligometastatic non-small cell lung cancer: Interim results of a randomized phase III, open-label clinical trial (SINDAS) (NCT02893332).

Session: Lung Cancer—Non-Small Cell Metastatic

Author(s): Xiaoshan Wang, Ming Zeng

Abstract: 9508

EGFR基因型寡集中于非小人体内肠肺癌病变梯队酪氨酸趋化因子衍生物协同或不协同务实前里央线大面积超声：III期闭馆首页外科随机次测试（SINDAS）的里叶结果（NCT02893332）。

简介：肠肺癌-非小人体内集中于

写作者：四川省暴政疗养院曾铭任教等

概述：9508

Overall survival and biomarker ysis of a phase Ib combination study of toripalimab, a humanized IgG4 mAb against programmed death-1 (PD-1) with axitinib in patients with metastatic mucosal melanoma.

Session: Melanoma/Skin Cancers

Author(s): Xinan Sheng, Xieqiao Yan, Zhihong Chi, Lu Si, Chuanliang Cui, Bixia Tang, Siming Li, Lili Mao, BIN LIAN, Xuan Wang, Xue Bai, Li Zhou, Yan Kong, Jie Dai, Keith Flaherty, Jun Guo

Abstract: 10007

Toripalimab，一种针对程序病态死亡-1（PD-1）的人源化IgG4化学合成协同阿昔替尼用做集中于病态黏膜黑色素腺病变的Ib期深入研究的总生存期和生物；也数据分析。

简介：黑色素腺/皮肤肺癌

写作者：北京大学疗养院郭军、盛锡楠任教等

概述：10007

Safety and efficacy results of GC027: The first-in-human, universal CAR-T cell therapy for relapsed/refractory T-cell acute lymphoblastic leukemia (r/r T-ALL).Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Xinxin Wang, Shiqi Li, Lei Gao, Zhongtao Yuan, Kun Wu, Lin Liu, Le Luo, Yao Liu, Cheng Zhang, Jia Liu, Chunhui Yang, Yu Li, Jiaping He, Xun Ye, Zhimin Li, Xu Tan, Jianning Ge, Wei Cao, Sanbin Wang, Xi ZhangAbstract: 3013Poster: 77 GC027的安全病态和结果：通用CAR-T人体内首次人体次测试复发住院/难治病态T人体内急病态淋巴人体内乳腺癌（r/r T-ALL）的安全病态和。内阁会议：开发计划里的复发技术-免疫复发。写作者：王立马等概述：3013剧照：77 Sintilimab in patients with advanced esophageal squamous cell carcinoma refractory to previous chemotherapy: A randomized, open-label phase II trial (ORIENT-2).Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Jianming Xu, Yi Li, Qingxia Fan, Yongqian Shu, Zhijun Wu, Tongjian Cui, Kangsheng Gu, Min Tao, Xiuwen Wang, Chengxu Cui, Nong Xu, Juxiang Xiao, Quanli Gao, Yunpeng Liu, Tao Zhang, Hui Zhou, Yan Wang, Linxinyu Xu, Zhuo Ma, Yanqi WangAbstract: 4511Poster: 119 信迪利单抗在里叶食管点状人体内肺癌病变里的广泛应用：一项随机的闭馆首页II期次测试（ORIENT-2）。内阁会议：肠胃肠道肺癌-肠胃食管肺癌、肺癌变肺癌和实为道肺癌写作者：徐建明任教等概述：4511剧照：119 Eradication of medulloblastoma by NKG2D-specific CAR T-cells.Session: Central Nervous System TumorsAuthor(s): Hong-jiu Dai, Bin Sun, Dong Yang, Hui Xu, Jingjing Zhu, Jia Wei, Xudong ZhaoAbstract: 2522Poster: 13 NKG2D特异病态CAR-T人体内对髓母人体内腺的发挥作用病态复发内阁会议：里枢神经系统写作者：代红久、孙斌、杨东、徐晖、李晶晶、魏佳、赵旭东概述：2522剧照。13 Envafolimab (KN035) in advanced tumors with mismatch-repair deficiency.Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Lin Shen, Jian Li, Yanhong Deng, Weijie Zhang, Aiping Zhou, Weijian Guo, Jianwei Yang, Ying Yuan, Liangjun Zhu, Shukui Qin, Silong Xiang, Haolan Lu, John Gong, Ting Xu, Did LiuAbstract: 3021Poster: 85 Envafolimab（KN035）在里叶错配修复瑕疵病变里的广泛应用内阁会议：开发计划里的复发学-免疫复发写作者：沈琳任教等概述：3021剧照。85 First-in-human clinical trial of the autologous CD7-CART for relapsed/refractory ACUTE lymphoblastic leukemia/lymphoma.Session: Developmental Therapeutics—ImmunotherapyAuthor(s): Mingzhi Zhang, Lin Yang, Xiaorui Fu, Lei Zhang, Huimin Meng, Ling Li, Xin Li, Xinhua Wang, Zhenchang Sun, Hui Yu, Zhaoming Li, Feifei Nan, Yu Chang, Zhiyuan Zhou, Jiaqin Yan, Jiwei Li, Min Wang, Fengtao You, Yu-Sheng Chen, Bozhen ZhangAbstract: 3026Poster: 90 自体CD7-CART复发住院/难治病态ACUTE淋巴人体内乳腺癌/淋巴腺的唯一未人体外科次测试内阁会议: 开发计划病态复发学-免疫复发写作者简介：张明志，杨林等概述：3026剧照: 90 A phase Ib study of simmitecan (LP) single-agent and in combination with 5-fluorouracil/leucovorin (5-FU/LV) or thalidomide (T) in patients with advanced solid tumor.Session: Developmental Therapeutics—Molecularly Targeted Agents and Tumor BiologyAuthor(s): Jifang Gong, Ting Deng, Jie Li, Ming Lu, Jian Li, Yi Ba, Qiuqiong Yu, Lin ShenAbstract: 3523Poster: 253 昂替康（LP）单药和5-氟尿嘧啶/白藜芦醇（5-FU/LV）或沙利度胺（T）协同运用里叶实体腺病变的Ib期深入研究内阁会议：发展病态复发学--化学键凋亡药物和生物学写作者：龚继芳，沈琳任教等概述：3523剧照：253 A phase II study of rh-endostatin combined with paclitaxel and nedaplatin in treating patients with recurrent or metastatic esophageal squamous cell carcinoma (ESCC).Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Zhiqiang Wang, Yu-Hong Li, De-Shen Wang, Fenghua Wang, Chao Ren, Qiong TanAbstract: 4522Poster: 130 Rh-endostatin协同萘和nedaplatin复发住院病态或集中于病态食管点状人体内肺癌（ESCC）病变的II期深入研究。内阁会议：肠胃肠道肺癌-肠胃食管、肺癌变和实为道肺癌的深入研究写作者：王志超强，蔡玉红，王德申，王凤华，任超，谭琼 王志超强、蔡玉红、王德深、王凤华、任超、谭琼概述：4522剧照：130 HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric adenocarcinoma: A phase II clinical trial.Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and HepatobiliaryAuthor(s): Yan Song, Ning Li, Lan Mu, Shu Zhang, Qingxia Fan, Xinjun Liang, Xianli Yin, Zhixiang Zhuang, Yunpeng Liu, Jingdong Zhang, Xiaoge Kou, Haijun Zhong, Jing HuangAbstract: 4524Poster: 132 HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric adenocarcinoma: A phase II clinical trial.内阁会议：肠胃肠道肺癌-肠胃食管肺癌、肺癌变肺癌和实为管肺癌的二里央线复发写作者：宋艳等概述：4524剧照：132 A urine exosomal circRNA classifier for detection of high-grade prostate cancer at initial biopsy: A multicenter, retrospective study.Session: Genitourinary Cancer—Prostate, Testicular, and PenileAuthor(s): Liaoyuan Li, Wen Tao, Yadi He, Tao He, Qing Li, Zhenquan Wu, Weiming Deng, Lingxiao ZhangAbstract: 5522Poster: 103 一种尿外体环状RNA分类器用做初始前列腺时检测高等级肺癌的尿外体环状RNA分类器：一项多为里心的回顾病态深入研究内阁会议：泌尿胎盘肺前列腺癌---肺癌、睾丸肺癌和肺癌写作者简介：Liaoyuan Li等概述：5522剧照。103 Adjuvant chemotherapy after concurrent chemoradiation therapy for locally advanced cervical cancer.Session: Gynecologic CancerAuthor(s): Lingna Kou, Tao Zhang, Siyun Peng, Yifei Wang, Mingyang Yuan, Minmin LiAbstract: 6031Poster: 202 大面积里叶宫颈肺癌并发复发后的除此以外复发内阁会议: 妇科肺前列腺癌写作者简介： 蔡珉珉等概述：6031剧照：202 Association between calcitonin and efficacy of anlotinib in medullary thyroid carcinoma: An ysis based on the ALTER01031 trial.Session: Head and Neck CancerAuthor(s): Ming Gao, Yihebali Chi, Pingzhang Tang, Zhengang Xu, Xiangqian Zheng, Dapeng Li, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng, Zhendong Li, Hui Liu, Jianwu Qin, Jingqiang Zhu, Ruochuan ChengAbstract: 6526Poster: 187 降钙素与安罗替尼复发病变髓病态肺癌的相关病态：基于ALTER01031次测试的数据分析。会话：细弱写作者：天津市人民政府疗养院高明任教概述：6526剧照。187 Influence of Eastern Cooperative Oncology Group performance status (ECOG PS), tumor size and age on patient outcomes after anlotinib treatment: A subgroup ysis based on ALTER01031 trial for medullary thyroid carcinoma (MTC).Session: Head and Neck CancerAuthor(s): Ming Gao, Yihebali Chi, Xiangqian Zheng, Dapeng Li, Pingzhang Tang, Zhengang Xu, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng, Zhendong Li, Hui Liu, Jianwu Qin, Jingqiang Zhu, Ruochuan ChengAbstract: 6527Poster: 188 ECOG PS、不等和岁数对安洛替尼复发后病变上集的严重影响: ALTER01031的亚组数据分析内阁会议：细弱写作者：天津市人民政府疗养院高明任教概述：6527剧照。188 Circulating tumor DNA (ctDNA) ysis predicts recurrence following surgery in patients with stage I-IIIA non-small-cell lung cancer (NSCLC): Results of GASTO1035 and GASTO1018.Session: Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic CancersAuthor(s): Si-Yu Wang, Ning Li, Wei Ou, Chao Cheng, Peng-Peng Kuang, Hui-Qi WuAbstract: 9023Poster: 216 ctDNA数据分析预测I-IIIA期非小人体内肠肺癌（NSCLC）病变术后住院: GASTO1035和GASTO1018的结果内阁会议：肠肺癌-非小人体内大面积-周边病态/小人体内/小人体内/其他胸科肺前列腺癌写作者：Si-Yu Wang等概述：9023剧照：216 Exon-16-skipping ERBB2 (ERBB2ΔEx16) as a novel resistance mechanism against EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC).Session: Lung Cancer—Non-Small Cell MetastaticAuthor(s): Xin Zhao, Linling Jin, Man Yu, Qiuxiang Ou, Hua Bao, Xue Wu, Yang Shao, Min FanAbstract: 9528Poster: 294 ERBB2ΔEx16作为非小人体内肠肺癌（NSCLC）里EGFR酪氨酸趋化因子衍生物的上新型耐药性系统内阁会议:肠肺癌-非小人体内集中于病态肠肺癌写作者简介：赵昕，金MLT-，满宇，欧秋香，宝珠，薛武，杨少，范敏 赵昕、金MLT-、满宇、欧秋香、宝珠、薛武、杨绍、范敏概述：9528剧照：294 Surrogate endpoints for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials of advanced melanoma.Session: Melanoma/Skin CancersAuthor(s): Run-Cong Nie, Shu-Qiang Yuan, Yuanfang Li, Yingbo Chen, Zhiwei ZhouAbstract: 10030Poster: 379 PD-1/PD-L1次测试里里叶黑色素腺总生存的替代起点内阁会议：黑色素腺/皮肤肺癌写作者：聂润聪，袁书超强，蔡元芳，陈英波，周志伟 聂润聪、袁书超强、蔡元芳、陈英波、周志伟概述：10030剧照：379 A phase II study of anlotinib in treating patients with relapsed or metastatic primary malignant bone tumor.Session: SarcomaAuthor(s): Lina Tang, Xiaohui Niu, Zhen Wang, Qiqing Cai, Chongqi Tu, Zhengfu Fan, Yang YaoAbstract: 11525Poster: 413 安罗替尼复发住院或集中于病态原发病态恶病态骨病变的II期深入研究内阁会议： 遗传性写作者：唐丽娜，牛晓辉，王震，蔡启清，涂崇奇，范正福，杨瑶 唐丽娜、牛晓辉、王振、蔡启庆、涂崇奇、范正福、杨瑶概述：11525剧照。413 Preliminary evaluate the safety and efficacy of anlotinib in advanced sarcoma patients in multi-line therapy.Session: SarcomaAuthor(s): Yao Weitao, Jiaqiang Wang, Peng Zhang, Xin Wang, Xinhui Du, Zhichao Tian, Xiaoying NiuAbstract: 11526Poster: 414 初步赞赏安罗替尼在里叶遗传性病变多里央线复发里的安全病态和。内阁会议：遗传性写作者：姚伟涛，来由超强，浙江余姚人，王欣，杜上新辉，田志浩，牛晓颖 姚伟涛、来由超强、浙江余姚人、王鑫、杜鑫辉、田志超、牛晓英概述：11526剧照：414